510(k) K260770

LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX by DiaSorin, Inc. — Product Code LOM

K260770 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX". The FDA issued a decision of Substantially Equivalent on Jun 4, 2026. The device falls under product code LOM (Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)), a Class II device regulated under 21 CFR 866.3172. DiaSorin, Inc. has 73 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jun 4, 2026
Date Received
Mar 9, 2026
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Device Class
Class II
Regulation Number
866.3172
Review Panel
MI
Submission Type
510(k)

In vitro diagnostic device intended for aid in the diagnosis of chronic or acute HBV infection. HBV surface antigen (HbsAg) is also used for screening of HBV infection in pregnant women to identify neonates who are at risk of acquiring hepatitis B during perinatal period.

Need the full FDA record for DiaSorin, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K260770. Report a data issue: hello@regdatalab.com.